Jong Lee

Jong Lee is a seasoned professional with over 25 years of experience in the medical technology industry, known for his leadership as the CEO and cofounder of Day Zero Diagnostics. His innovative approach has led to the development of a revolutionary solution for infectious disease diagnostics, integrating sample preparation, genome sequencing, and machine learning.

With a strong educational background from Harvard Business School and Harvard University, Jong has a profound understanding of corporate finance, healthcare, social studies, and international political economy, enriching his strategic approach to business development and product commercialization.

Throughout his career, Jong has garnered numerous accolades and awards such as the MedTech Innovator Grand Prize, Harvard Presidential Innovation Award, AACC Disruptive Technology Award, and UCSF Health Award, showcasing his commitment to advancing the healthcare industry through disruptive technologies.

Jong's expertise spans various domains including corporate strategy, product development, marketing, fundraising, and business development. He has a successful track record in commercializing cutting-edge medical devices with a focus on interventional cardiology, orthopedics, and diagnostics.

In addition to his role at Day Zero Diagnostics, Jong has also been actively involved in advising and investing in startups within the medical technology sector, notably contributing to the success of Resolution Biosciences which was later acquired by Agilent.

Jong Lee's mission is rooted in leveraging his vast experience and extensive network to introduce innovative solutions to the global healthcare market, with the ultimate goal of enhancing patient outcomes and driving positive disruptions in the industry.